Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  2008-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.2008.01223.xPMID 18699953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incentive motivation is associated with striatal dopamine asymmetry.

  2008cited by this paper
• Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age

  2007cited by this paper
• Test Wisconsin chez les patients souffrant de schizophrénie, et leurs frères et soeurs

  2006cited by this paper
• [Wiscosin card sorting task in patients with schizophrenia and thier siblings].

  2006cited by this paper
• Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.

  2005cited by this paper
• Psychometric schizotypy modulates levodopa effects on lateralized lexical decision performance.

  2005cited by this paper
• Childhood onset schizophrenia: familial neurocognitive measures.

  2004cited by this paper
• Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.

  2003cited by this paper
• Familial loading associates with impairment in visual span among healthy siblings of schizophrenia patients.

  2003cited by this paper
• Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2, 3 receptors in pig brain

  2003cited by this paper
• Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model

  2003cited by this paper
• Mapping brain asymmetry

  2003cited by this paper
• Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan.

  2002cited by this paper
• Wisconsin Card Sorting deficits in the offspring of schizophrenics in the New York High-Risk Project.

  2002cited by this paper
• Dopamine receptors in the brains of schizophrenia patients: a meta‐analysis of the findings

  2001cited by this paper
• A Simple Method to Measure Baseline Occupancy of Neostriatal Dopamine D2 Receptors by Dopamine In Vivo in Healthy Subjects

  2001cited by this paper
• Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia.

  2001cited by this paper
• Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

  2000influential reference
• Schizophrenia: genes and environment

  2000cited by this paper
• Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

  2000cited by this paper
• The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia.

  2000cited by this paper
• Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.

  1999cited by this paper
• Assessment of spatial normalization of PET ligand images using ligand-specific templates.

  1999cited by this paper
• Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

  1999cited by this paper
• Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

  1999cited by this paper
• Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS)

  1999cited by this paper
• Left-right asymmetry of striatal dopamine D2 receptors.

  1998cited by this paper
• Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

  1998cited by this paper
• Differential aging of the human striatum: a prospective MR imaging study.

  1998cited by this paper
• Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness

  1997cited by this paper
• Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet

  1997cited by this paper
• Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia

  1997cited by this paper
• Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.

  1997cited by this paper
• Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans

  1997cited by this paper
• Quantitative magnetic resonance imaging of human brain development: ages 4-18.

  1996cited by this paper
• Simplified reference tissue model for PET receptor studies.

  1996cited by this paper
• Impact of age on drawing the Rey-Osterrieth figure

  1995cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients

  1994cited by this paper
• Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

  1994cited by this paper
• Schizophrenia epigenesis: past, present, and future

  1994cited by this paper
• The genetics of schizophrenia: a current, genetic-epidemiologic perspective.

  1993cited by this paper
• The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

  1992cited by this paper
• Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brain

  1991cited by this paper
• D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

  1990cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.

  1988cited by this paper
• Dopamine receptor asymmetry in schizophrenia.

  1987cited by this paper
• Rotational movement (circling) in normal humans: sex difference and relationship to hand, foot and eye preference.

  1987cited by this paper
• Cerebral Lateralization: Biological Mechanisms, Associations, and Pathology

  1987cited by this paper
• Cerebral lateralization: biological mechanisms, associations and pathology

  1987cited by this paper
• Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

  1986cited by this paper
• Asymmetry in D-2 binding in female rat striata.

  1986cited by this paper
• Asymmetrical volumes of the right and left frontal and occipital regions of the human brain

  1982cited by this paper
• Increased brain dopamine and dopamine receptors in schizophrenia.

  1982cited by this paper
• Elevation of brain neuroleptic/dopamine receptors in schizophrenia.

  1980cited by this paper
• MORPHOLOGICAL CEREBRAL ASYMMETRIES OF MODERN MAN, FOSSIL MAN, AND NONHUMAN PRIMATE

  1976cited by this paper
• Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms.

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper

• Meta‐Analysis of Brain Structure in Magnetic Resonance Imaging Studies of Adolescents With Schizophrenia

  2025cites this paper
• Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities

  2024cites this paper
• A Brief History and the Use of PET in the Diagnosis and Management of Schizophrenia: An Educational Review.

  2024cites this paper
• Dopaminergic alterations in populations at increased risk for psychosis: a systematic review of imaging findings.

  2022influential citation
• Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls

  2021cites this paper
• Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

  2020cites this paper
• Twin studies of brain structure and cognition in schizophrenia.

  2019cites this paper
• The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.

  2017cites this paper
• Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics

  2016cites this paper
• The role of genes, stress and dopamine in the development of schizophreniaDopamine and the prodrome in the development of schizophreniaDopamine

  2016cites this paper
• Dopamine Receptor Imaging in Schizophrenia: Focus on Genetic Vulnerability

  2014cites this paper
• The XY Gene Hypothesis of Psychosis: Origins and Current Status

  2013cites this paper
• A review of cognitive neuropsychiatry in the taxonomy of eating disorders: State, trait, or genetic?

  2013cites this paper
• Imaging as tool to investigate psychoses and antipsychotics.

  2012cites this paper
• Neuroimaging studies in schizophrenia: An overview of research from Asia

  2012cites this paper
• Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence.

  2012cites this paper
• The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia

  2011cites this paper
• Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems

  2011cites this paper
• An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

  2010cites this paper
• Basal ganglia pathology in schizophrenia: dopamine connections and anomalies

  2010cites this paper
• Current awareness in human psychopharmacology.

  2009cites this paper